Skip to contentSkip to navigation
TwitterLinkedInInstagram
  • Home
  • News
  • Events
  • Covid-19 Statement
  • Contact Us
  • Search this site

NovaBiotics fast-tracks COVID-19 drug | ONE

Site Navigation

  • About ONE
    nav-arrow About ONE
    nav-arrow Transformational Leadership and Action
    nav-arrow Who We Are
    nav-arrow Delivery and Impact
    nav-arrow Regional Economy
    nav-arrow ONE Enterprise Fund
    ONE invests in transformational technology
    ONE invests in transformational technology
    BioHub construction phase
    BioHub construction phase
    SeedPod reaches key milestone
    SeedPod reaches key milestone
  • Transformational Projects
    nav-arrow Transformational Projects
    nav-arrow Energy Transition
    nav-arrow Seafood Transformation
    BioHub construction phase
    BioHub construction phase
    Chancellor announces financial support for Energy Transition Zone
    Chancellor announces financial support for Energy Transition...
    SeedPod reaches key milestone
    SeedPod reaches key milestone
  • Digital & Entrepreneurship
    nav-arrow Digital & Entrepreneurship
    nav-arrow Transformational Leadership and Action
    nav-arrow ONE Tech Hub
    nav-arrow Accelerate Growth
    nav-arrow Digital Catalyst
    nav-arrow Internationalisation and Market Development
    nav-arrow Strategic Partnerships
    nav-arrow EnergyTech
    Future Skills Partnership launched
    Future Skills Partnership launched
    New business growth and recovery programme
    New business growth and recovery programme
    EnergyTech to create culture of cooperation
    EnergyTech to create culture of cooperation
  • Energy
    nav-arrow Energy
    nav-arrow Transformational Leadership and Action
    nav-arrow Energy Transition
    nav-arrow Accelerate Growth
    nav-arrow Digital Catalyst
    nav-arrow Internationalisation and Market Development
    nav-arrow Strategic Partnerships
    North Sea deal to protect jobs in green energy transition
    North Sea deal to protect jobs in green energy transition
    Global Underwater Hub receives additional £5m funding
    Global Underwater Hub receives additional £5m funding
    Chancellor announces financial support for Energy Transition Zone
    Chancellor announces financial support for Energy Transition...
  • Food, Drink & Agriculture
    nav-arrow Food, Drink & Agriculture
    nav-arrow Transformational Leadership and Action
    nav-arrow SeedPod
    nav-arrow Accelerate Growth
    nav-arrow Transform Food Production
    nav-arrow Internationalisation and Market Development
    nav-arrow Strategic Partnerships
    Seafood industry recruitment campaign
    Seafood industry recruitment campaign
    New food and drink campaign
    New food and drink campaign
    SeedPod reaches key milestone
    SeedPod reaches key milestone
  • Life Sciences
    nav-arrow Life Sciences
    nav-arrow Transformational Leadership and Action
    nav-arrow BioHub
    nav-arrow Accelerate Growth
    nav-arrow Digital Catalyst
    nav-arrow Internationalisation and Market Development
    nav-arrow Strategic Partnerships
    BioHub construction phase
    BioHub construction phase
    ONE supports life sciences entrepreneurs
    ONE supports life sciences entrepreneurs
    Life sciences start-up ideas secure development support
    Life sciences start-up ideas secure development support
  • Tourism
    nav-arrow Tourism
    nav-arrow Transformational Leadership and Action
    nav-arrow VisitAberdeenshire
    nav-arrow Accelerate Growth
    nav-arrow Gourmet Food Festival
    nav-arrow North East Adventure Tourism
    Selling adventure tourism
    Selling adventure tourism
    Adventure tourism insights
    Adventure tourism insights
    Adventure tourism to support economic recovery
    Adventure tourism to support economic recovery
  • Home
  • News
  • Events
  • Covid-19 Statement
  • Contact Us
News
Life Sciences
Posted: 14 May 2020
NovaBiotics fast-tracks drug for COVID-19

North east Scotland’s proven life sciences strength in the development of novel biotherapeutics is being applied to the challenge of the COVID-19 pandemic.

NovaBiotics, the Aberdeen-based clinical stage antimicrobials drug discovery company, has announced the rapid repurposing of its experimental drug Nylexa for the ‘hidden killer’ underlying COVID-19: secondary bacterial lung infections.

The active ingredient of Nylexa is already in advanced clinical trials. It has proven to be safe and effective in clinical studies carried out across the UK, Italy and the US for the complex bacterial lung infections associated with cystic fibrosis. Nylexa could be rapidly re-positioned as a COVID-19 therapy and tested in patients in the second half of 2020.

Nylexa works to boost the body’s ability to fight infection and modulates the immune response to pathogen challenge. Nylexa also ‘supercharges’ antibiotics, boosting their efficacy against difficult to treat and even drug resistant bacteria. More than 50% of the COVID-19 patients who died in Hubei province, China, succumbed to a bacterial infection/sepsis, despite having been given antibiotic therapy. Secondary bacterial pneumonia is such as risk to clinical outcomes of COVID-19 that patients are started on antibiotic therapy to prevent this as soon as they are hospitalised. This increased use of antibiotics will undoubtedly exacerbate antibiotic resistance in the near future.

Deborah O’Neil, CEO of NovaBiotics commented: “A vaccine for COVID-19 is not certain and we must look to develop therapies that can truly change the trajectory of this disease. Nylexa is unique in that it tackles both the infectious elements of COVID-19 and the body’s response to the SARS-CoV-2 virus. This could deliver significant and clinically meaningful benefit, particularly for the most vulnerable patients with secondary bacterial pneumonia. The impact of bacterial infections and antibiotic resistance in COVID-19 is beyond doubt. Our strategy to expedite Nylexa’s development to address this aligns 100% with the UK Government’s ‘wave 2 COVID-19 clinical trials’ strategy to test repurposed experimental therapies already in late stage clinical trials for other indications. Whilst ‘wave 1’ focused on the potential benefit of repurposed, already licensed antiviral and antimalarial therapies. Nylexa is low risk, low cost, readily available and scalable candidate treatment that could be tested and deployed to combat the coronavirus pandemic very quickly.”

Read more on the NovaBiotics website.

ONE LS Deborah O NeilDeborah O'Neil is CEO of Aberdeen-based drug discovery company NovaBiotics.
Stay up to date
Sign up to Opportunity North East’s newsletter to hear about our latest sector events and regional news.

Your privacy matters to us so if you want to find out more on how we keep your data safe, view our Privacy Notice or talk to ONE direct.

news
ONE invests in transformational technology
Mar 26 2021
North Sea deal to protect jobs in green energy transition
Mar 24 2021
BioHub construction phase
Mar 24 2021
twitterTweets by OpportunityNE_1
contact

Opportunity North East Ltd

11 Queens Gardens
Aberdeen
AB15 4YD

+44 (0)1224 061100

info@opportunitynortheast.com

  • About One
    Transformational Leadership and ActionWho We AreDelivery and ImpactRegional EconomyONE Enterprise Fund
  • Transformational Projects
    Energy TransitionSeafood Transformation
  • Digital & Entrepreneurship
    Transformational Leadership and ActionONE Tech HubAccelerate GrowthDigital CatalystInternationalisation and Market DevelopmentStrategic PartnershipsEnergyTech
  • Energy
    Transformational Leadership and ActionEnergy TransitionAccelerate GrowthDigital CatalystInternationalisation and Market DevelopmentStrategic Partnerships
  • Food, Drink & Agriculture
    Transformational Leadership and ActionSeedPodAccelerate GrowthTransform Food ProductionInternationalisation and Market DevelopmentStrategic Partnerships
  • Life Sciences
    Transformational Leadership and ActionBioHubAccelerate GrowthDigital CatalystInternationalisation and Market DevelopmentStrategic Partnerships
  • Tourism
    Transformational Leadership and ActionVisitAberdeenshireAccelerate GrowthGourmet Food FestivalNorth East Adventure Tourism
ONE (en-GB)
Privacy Policy | Terms and Conditions